MYC and neoplasm: The proliferating subgroup of tumor cells showed enrichment in the cell cycle- and cell metabolism-related signaling pathways, including E2F/MYC targets, G2/M checkpoint, DNA repair and fatty acid metabolism (Fig. 3g).